Cargando…

Flu DRiPs in MHC Class I Immunosurveillance

Since the publication of the DRiP (defective ribosomal product) hypothesis in 1996, numerous studies have addressed the contribution of DRiPs to generating viral antigenic peptides for CD8(+) T cell immunosurveillance. Here, we review studies characterizing the generation of antigenic peptides from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Jiajie, Yewdell, Jonathan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513827/ https://www.ncbi.nlm.nih.gov/pubmed/30456657 http://dx.doi.org/10.1007/s12250-018-0061-y

Ejemplares similares

MHC Class I Immunopeptidome: Past, Present, and Future
por: Yewdell, Jonathan W.
Publicado: (2022)

Casting a wider net: Immunosurveillance by nonclassical MHC molecules
por: D’Souza, M. Patricia, et al.
Publicado: (2019)

MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
por: Walter, W, et al.
Publicado: (2000)

MHC Class I Antigen Presentation of DRiP-Derived Peptides from a Model Antigen Is Not Dependent on the AAA ATPase p97
por: Palmer, Amy L., et al.
Publicado: (2013)

A transient transfection system for identifying biosynthesized proteins processed and presented to class I MHC restricted T lymphocytes
por: Eisenlohr, Laurence C., et al.
Publicado: (1992)

SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression
por: Alam, Aftab, et al.
Publicado: (2019)

Novel insights into the HLA class I immunopeptidome and T-cell immunosurveillance
por: Melief, Cornelis J. M., et al.
Publicado: (2017)

Positional Bias of MHC Class I Restricted T-Cell Epitopes in Viral Antigens Is Likely due to a Bias in Conservation
por: Kim, Yohan, et al.
Publicado: (2013)

MHC class I multimers
por: Sun, Mei-Yi, et al.
Publicado: (2001)

Immunosurveillance of cancer cell stress
por: Lorenzo-Herrero, Seila, et al.
Publicado: (2019)

TYK2 in Tumor Immunosurveillance
por: Karjalainen, Anzhelika, et al.
Publicado: (2020)

The Human Immunodeficiency Virus Type 1 (HIV-1) Vpu Protein Interferes with an Early Step in the Biosynthesis of Major Histocompatibility Complex (MHC) Class I Molecules
por: Kerkau, Thomas, et al.
Publicado: (1997)

Cancer immunosurveillance by CD8 T cells
por: Crispin, José C, et al.
Publicado: (2020)

The Role of TRAIL in Apoptosis and Immunosurveillance in Cancer
por: Pimentel, Julio M., et al.
Publicado: (2023)

The mode of action of tapasin on major histocompatibility class I (MHC-I) molecules
por: Lan, By Huan, et al.
Publicado: (2023)

Role of non-classical MHC class I molecules in cancer immunosuppression
por: Kochan, Grazyna, et al.
Publicado: (2013)

The role of MHC class I gene products in SIV infection of macaques
por: Silver, Zachary A., et al.
Publicado: (2017)

Variations in MHC class I antigen presentation and immunopeptidome selection pathways
por: Zaitouna, Anita J., et al.
Publicado: (2020)

MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It
por: Shklovskaya, Elena, et al.
Publicado: (2021)

MHC class I diversity in chimpanzees and bonobos
por: Maibach, Vincent, et al.
Publicado: (2017)

MHC Class I Regulation: The Origin Perspective
por: Sznarkowska, Alicja, et al.
Publicado: (2020)

Non-conventional sources of peptides presented by MHC class I
por: Starck, Shelley R., et al.
Publicado: (2011)

On immunosurveillance in human cancer.
por: Thomas, L.
Publicado: (1982)

MHC class I characterization of Indonesian cynomolgus macaques
por: Pendley, Chad J., et al.
Publicado: (2008)

Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
por: Wieczorek, Marek, et al.
Publicado: (2017)

Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy
por: Ichim, Christine V
Publicado: (2005)

Open MHC Class I Conformers: A Look through the Looking Glass
por: Arosa, Fernando A., et al.
Publicado: (2021)

MHC Class II Presentation in Autoimmunity
por: Ishina, Irina A., et al.
Publicado: (2023)

The role of the proteasome in the generation of MHC class I ligands and immune responses
por: Sijts, E. J. A. M., et al.
Publicado: (2011)

The MHC class I peptide repertoire is molded by the transcriptome
por: Fortier, Marie-Hélène, et al.
Publicado: (2008)

Predicting MHC class I epitopes in large datasets
por: Roomp, Kirsten, et al.
Publicado: (2010)

Involvement of autophagy in MHC class I antigen presentation
por: Øynebråten, Inger
Publicado: (2020)

Mechanistic diversity in MHC class I antigen recognition
por: Barbosa, Camila R. R., et al.
Publicado: (2021)

MHC class I–deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I–sufficient environment
por: Elliott, Julie M., et al.
Publicado: (2010)

Differential MHC class I expression in distinct leukocyte subsets
por: Greene, Justin M, et al.
Publicado: (2011)

Homotypic and heterotypic in cis associations of MHC class I molecules at the cell surface
por: Ruggiero, Fernando M., et al.
Publicado: (2022)

Recent advances in Major Histocompatibility Complex (MHC) class I antigen presentation: Plastic MHC molecules and TAPBPR-mediated quality control
por: van Hateren, Andy, et al.
Publicado: (2017)

Discovery of an ancient MHC category with both class I and class II features
por: Okamura, Kazuhiko, et al.
Publicado: (2021)

Escape from IFN-γ-dependent immunosurveillance in tumorigenesis
por: Lin, Chiou-Feng, et al.
Publicado: (2017)

Immunosurveillance by human γδ T lymphocytes: the emerging role of butyrophilins
por: Kabelitz, Dieter, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r4nkukkn83dbt8tmrj6kgvvjba